November 22, 2017

PET Imaging May Predict Drug Response, Survival in Advanced Prostate Cancer

Positron emission tomography (PET)-based molecular imaging biomarkers may predict therapeutic response and survival in patients with metastatic castration-resistant prostate cancer (mCRPC), researchers say. {read more here}